Bloom Health Partners (CSE: BLMH) has not disappointed with its FQ2 financial results.
Revenue grossed CAD $11.1 million for the period ending March 31, 2022, bringing Bloom’s year-to-date revenue to CAD $16.9 million for the first half of F2022. Considering the company’s current valuation of CAD $7.01 million, these results are highly impressive.
As previously announced on February 9, 2022, Bloom anticipates FY 2022 revenues of CAD $25M - $28M from continued business with new and existing clients and markets. Given these recent results, it seems like the company is remaining on track to meet this guidance.
$BLMH.c is currently trading at $.18, up a staggering 50% following this announcement.
https://ceo.ca/@newsfile/bloom-health-partners-reports-profitable-fiscal-q2